Director/PDMR Dealing

RNS Number : 7263M
Calnex Solutions PLC
13 January 2023
 

13 January 2023

Calnex Solutions plc

("Calnex" or the "Company")

Director / PDMR Dealings

Calnex Solutions plc (AIM: CLX), an established provided of test and measurement solutions for the global telecommunications sector, confirms the following transaction in the Company's ordinary shares.

The information in the below notification is disclosed in accordance with Article 19 of the EU Market Abuse Regulation.

Details of PDMR/person closely associated with them ("PCA")

1.1 

Name

Ashleigh Greenan

1.2 

Position/Status

CFO/Director

1.3 

Initial notification / amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

2.1 

Name

Calnex Solutions plc

2.2 

LEI

213800GY6TURGL3HYT04

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

3.1 

Description of the financial instrument

Identification code

Ordinary shares of  0.125 pence  each


GB00BMBK7016

3.2 

Nature of the transaction

Sale of Ordinary Shares

3.3 

Price(s) and volume(s)

Price(s)

Volume(s)

£ 1.93055

30,000

3.4 

Aggregated information

· Aggregated volume

· Price

 

 

30,000

 

£57,916.50

3.5 

Date of the transaction

  13th January 2023

3.6 

Place of the transaction

London Stock Exchange (AIM:CLX)

 

For more information, please contact:

Calnex Solutions plc

Via Alma PR

Tommy Cook, Chief Executive Officer

Ashleigh Greenan, Chief Financial Officer




Cenkos Securities plc - Nomad

+44 (0)131 220 6939

Derrick Lee / Peter Lynch




Alma PR

+ 44(0) 20 3405 0213

Caroline Forde, Hannah Campbell, Joe Pederzolli


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUOUVRONUAAAR
UK 100

Latest directors dealings